A Study to Assess the Safety of TPM502 in Adults With Celiac Disease
Clinical trial NCT05660109 · COMPLETED
Trial details
- NCT number
- NCT05660109
- Sponsor
- Topas Therapeutics GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-12
- Primary completion
- 2024-07-04
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.